LegitScript

Big Pharma Profits by Keeping Us Sick: The Truth Behind Chronic Treatments

Pharmaceutical companies operate on business models that emphasize continuous revenue streams, particularly through the treatment of chronic conditions like diabetes, hypertension, and high cholesterol. This approach contrasts sharply with the one-time profit from a cure. While treatments for diseases such as HIV and cancer generate ongoing revenue, the development and prioritization of cures face numerous economic and regulatory hurdles. Critics argue that Big Pharma’s focus on profit leads to the suppression of potential cures, and regulatory bodies and market control entities, like LegitScript, often act to maintain this status quo. This article examines the inherent economic incentives in the pharmaceutical industry that prioritize treatments over cures, the suppression of natural remedies, and the broader implications for global health.

Read more

LegitScript’s Influence: More Harm Than Good?

LegitScript, a private company with significant control over major tech and payment companies, influences what medications Americans can access and purchase online. This control supports big pharmaceutical companies by blocking affordable Indian generics, maintaining high drug prices. This article argues that such overreach undermines public health and calls for greater transparency and legislative intervention to ensure Americans have access to safe and affordable medications.

Read more

The Silent Conspiracy: How Regulators and Corporations Control Your Health

The regulatory landscape involving entities like the FDA, LegitScript, Meta, and Google is often seen as a guardian of public health. However, a closer look reveals that, much like underground steroid forums, these organizations control information and access to healthcare products for financial gain. This article explores the parallels between these mainstream and underground entities, highlighting how they prioritize profits over genuine healthcare needs. The discussion covers the manipulation of health information, censorship, and the economic interests driving these practices. It also advocates for regulatory reforms and supports organizations like Ashvin Medicara, which promote transparency and access to affordable medications.

Read more

The Dark Side of IndiaMART: Compromising Global Healthcare and Safety

IndiaMART, a major online marketplace, is under scrutiny for its role in the sale of pharmaceuticals. The platform’s lack of stringent verification processes and focus on bulk sales have led to the distribution of tainted medications, raising significant global health concerns. Incidents involving suppliers like QP Pharmachem highlight the dangers of unregulated pharmaceutical sales, including the risk of contamination with harmful substances. This article delves into the implications for global healthcare, the erosion of trust in legitimate Indian pharmacies, and the influence of regulatory bodies like LegitScript, emphasizing the need for stricter oversight and consumer awareness.

Read more

How Big Pharma, the FDA, Congress, and Shadow Organizations Violate Our Constitutional Rights to Healthcare

The American healthcare system is often lauded as one of the most advanced in the world, but beneath the surface lies a troubling reality of collusion involving Big Pharma, the FDA, Congress, and shadow organizations like LegitScript. These entities, created to protect public health, prioritize corporate profits over individual rights and access to affordable healthcare. This article exposes how these powerful groups manipulate regulations, lobby against public interests, and violate our constitutional rights to make healthcare choices. Through financial power, regulatory influence, and digital censorship, they maintain high drug prices and limit access to affordable medications. Reform is urgently needed to ensure transparency, accountability, and a healthcare system that serves the needs of the people.

Read more

Why Americans Must Turn to Cryptocurrency for Affordable Medications

The inability to use traditional payment methods like Visa, MasterCard, PayPal, and Venmo for purchasing affordable generic pharmaceuticals from India has inadvertently given rise to the use of cryptocurrency. This shift is not a result of criminal activity but a response to regulatory and corporate obstacles. This article explores how the blockage of normal payment channels has led to increased use of cryptocurrency, and how this shift impacts public perception and access to healthcare. By bypassing traditional payment processors influenced by Big Pharma, cryptocurrency offers a secure and legitimate method for consumers to access affordable medications, challenging the monopolistic practices that maintain high drug prices.

Read more

How Payment Processors and Shadow Regulation Prevent Americans from Accessing Affordable Generic Pharmaceuticals from India

Americans seeking affordable healthcare solutions often turn to generic pharmaceuticals from countries like India. However, they face significant barriers in using common payment methods such as Visa, MasterCard, PayPal, and Venmo to purchase these medications. This article explores how shadow regulation, particularly by LegitScript, influences payment processors to block transactions related to online pharmacies, and how Big Pharma and government collusion perpetuate these obstacles. The narrative portrays online generic pharmacies as fraudulent, while in reality, this is a form of commercial protectionism benefitting a select few. By recognizing these challenges and advocating for transparency, consumers can better navigate the complex landscape of pharmaceutical access.

Read more

Prohibition Redux: The Parallel Crises of Pharmaceutical Regulation and Access in America

The regulatory landscape of pharmaceuticals today mirrors the unintended consequences of Prohibition in the 1920s. Entities like LegitScript exert significant influence over online platforms, favoring big pharma by limiting competition and driving up drug prices. This has led to the rise of an online black market, endangering public health. Legitimate online pharmacies, offering affordable and safe medications, are stifled by these monopolistic practices. To ensure equitable healthcare, it’s crucial to advocate for transparency and reform in pharmaceutical regulations, learning from the historical lessons of Prohibition.

Read more

Shadow Pharmacy Regulation and Market Monopoly: The Case of LegitScript and PharmacyChecker

In the shadowy corridors where policy meets business, the conflict between PharmacyChecker and LegitScript underscores the struggle over who controls access to affordable healthcare in the U.S. LegitScript’s influential role in online pharmacy vetting, impacting major corporations like Google and Visa, highlights its significant, albeit unofficial, regulatory power. PharmacyChecker’s antitrust lawsuit challenges this control, alleging unfair market practices by LegitScript to monopolize online pharmacy information. This case could redefine the future of medication access in the U.S., drawing global attention to models like Ashvin Medicara, which promotes transparency and patient access over corporate dominance. The outcome will be pivotal for healthcare accessibility and the balance of consumer rights against corporate influence.

Read more